Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

Communicating Amyloid Neuroimaging (REVEAL-SCAN)

Start: November 2016
End: December 2021
Enrollment: 270

What Is This Study About?

This study examines the impact on older adults of learning the results of amyloid brain imaging, which can indicate risk for Alzheimer's disease. 

Do I Qualify To Participate in This Study?

Minimum Age: 65 Years

Maximum Age: 80 Years

Must have:

  • At least one first-degree relative (parent, sibling, child) with Alzheimer's disease
  • Study partner who will complete surveys and interviews and accompany subject to visits
  • Willingness to give a cheek swab for Alzheimer's-related genetic testing
  • English speaking

Must NOT have:

  • History of stroke or head trauma
  • Active medical or psychiatric illness that is unstable or progressive
  • Taking memantine

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Brigham and Women's Hospital

Collaborator Sponsor

  • University of Pennsylvania
  • University of Michigan
  • Duke University
  • Boston University
  • National Institute on Aging (NIA)

Source: ClinicalTrials.gov ID: NCT02959489

 

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health